Friday, Nov 27th

Last update07:41:34 AM GMT

You are here All News At a Glance Health Glance

Depths of heroin addiction: US sets record high for opium abuse

Heroin use up in USFrom 2002 to 2013, heroin dependence and abuse in the United States increased 90 percent, according to a report released by the Centers for Disease Control (CDC) in July. The rate of fatal overdoses quadrupled since 2000. Moreover, the number of Americans who said they’d used the drug in the last year went up by 65 percent; that means more than half a million people in the U.S. take heroin.

Notably, heroin use has been climbing among all demographic groups, including women, non-Hispanic whites, and the more affluent. Still, the growth in addiction has been most pronounced among white males between 18 and 25 years old.


FDA: Start-up's cancer blood test may be harmful

Start=up cancer blood test may be dangerousA San Diego company selling an early cancer detection test was notified by the U.S. Food and Drug Administration it can find no evidence the test actually works, and is concerned it could prove to be harmful for some people.

Pathway Genomics debuted its CancerIntercept test in early September with claims it can detect cancer cell DNA in the blood, picking up mutations linked to as many as 10 different cancers. The goal is to catch cancer early in people who are "otherwise healthy" and not showing symptoms of the disease.


Brain-computer connection helps paralyzed man walk

computer-brain helps paralyzed man walkA man's ability to walk using direct brain control of his legs was restored after years of being paralyzed, researchers reported in a proof-of-concept study.

The system uses electrical signals from the man's brain, sending them to electrodes placed on his knees, allowing him to voluntarily move his legs.

Previous research has shown paralysis patients can be made to move their legs with noninvasive treatments, however this study used virtual reality training and a harness system, rather than an exoskeleton to help the man support his weight.


Turing Pharmaceuticals decreasing Daraprim drug price after outrage

Skrelli to reduce drug priceMartin Shkreli, CEO of Turing Pharmaceuticals, announced he will reduce the price for Daraprim, a drug used to treat toxoplasmosis, after an earlier 5,000 percent price increase that generated mass criticism and accusations of drug-price gouging.

Shkreli, 32, told NBC News the new price would be determined in the coming weeks. He said lowering the price was a decision taken in reaction to the outrage over Daraprim's price surge.


US pharmaceutical company defends 5,000% price increase

Martin ShkrelliThe head of a US pharmaceutical company has defended his company's decision to raise the price of a 62-year-old medication used by Aids patients by over 5,000%.

Turing Pharmaceuticals acquired the rights to Daraprim in August.  CEO Martin Shkreli has said that the company will use the money it makes from sales to research new treatments.


The U.S. Doesn't Have Enough Of The Vegetables We're Supposed To Eat

Not enough vegetables for AmericansIf you are looking for proof that Americans' vegetable habits lean towards french fries and ketchup, the U.S. Department of Agriculture has it: Nearly 50 percent of vegetables and legumes available in the U.S. in 2013 were either tomatoes or potatoes. Lettuce came in third as the most available vegetable, according to new data out this week.

And while the USDA's own dietary guidelines recommend that adults consume 2.5 to 3 cups of vegetables a day, the agency's researchers found that only 1.7 cups per person are available.


Company hikes price 5,000% for drug that fights complication of AIDS, cancer

5000 percent raise in cancer side effects drugA drug treating a common parasite that attacks people with weakened immune systems increased in cost 5,000% to $750 per pill.

At a time of heightened attention to the rising cost of prescription drugs, doctors who treat patients with AIDS and cancer are denouncing the new cost to treat a condition that can be life-threatening.

Turing Pharmaceuticals of New York raised the price of Daraprim from $13.50 per pill to $750 per pill last month, shortly after purchasing the rights to the drug from Impax Laboratories. Turing has exclusive rights to market Daraprim (pyrimethamine), on the market since 1953.


Page 7 of 215

America's # 1 Enemy
Tee Shirt
& Help Support!
TVNL Tee Shirt
Conserve our Planet
& Help Support!
Get your 9/11 & Media
Deception Dollars
& Help Support!
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!